CureVac NV
NASDAQ:CVAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CureVac NV
NASDAQ:CVAC
|
DE |
|
C
|
Canadian Imperial Bank of Commerce
XMUN:CAI
|
CA |
|
D
|
Danieli & C Officine Meccaniche SpA
LSE:0APM
|
IT |
|
R
|
Ryanair Holdings PLC
OTC:RYAOF
|
IE |
|
Lindblad Expeditions Holdings Inc
NASDAQ:LIND
|
US |
|
BWP Trust
ASX:BWP
|
AU |
|
Meritage Homes Corp
NYSE:MTH
|
US |
|
P
|
PGE Polska Grupa Energetyczna SA
WSE:PGE
|
PL |
|
De La Rue PLC
LSE:DLAR
|
UK |
|
Verona Pharma PLC
NASDAQ:VRNA
|
UK |
|
Distribuidora Internacional de Alimentacion SA
OTC:DIDAF
|
ES |
|
Trilogy International Partners Inc
TSX:TRL
|
US |
|
Dianomi PLC
LSE:DNM
|
UK |
|
Ryanair Holdings PLC
NASDAQ:RYAAY
|
IE |
|
1
|
1-800-Flowers.Com Inc
XBER:FWC
|
US |
|
G
|
Gap Inc
SWB:GAP
|
US |
|
H
|
HP Inc
LSE:0J2E
|
US |
|
City Union Bank Ltd
BSE:532210
|
IN |
Bankruptcy Probability
CureVac NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
CureVac NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
CureVac NV
NASDAQ:CVAC
|
1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
150.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
CureVac NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, CureVac NV has total debt of 30.3m EUR. This includes both short-term (0 EUR) and long-term (30.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
